安慰剂在精神性运动障碍的治疗中有一席之地吗？
Is there a place for placebo in management of psychogenic movement disorders?
作者信息
Lim Erle C H, Ong Benjamin K C, Seet Raymond C S
机构信息
Division of Neurology, Department of Medicine, National University Hospital, Singapore.
出版信息
Ann Acad Med Singap. 2007 Mar;36(3):208-10.
INTRODUCTION
The management of psychogenic movement disorders is fraught with difficulties. Empathy and a non-judgmental manner are essential in dealing with patients, and a neurobiological explanation of the symptoms may help to foster trust, acceptance, understanding and recovery.
CLINICAL PICTURE
We report a 17-year-old Chinese girl with psychogenic blepharospasm. Her parents refused psychotherapy and pharmacotherapy.
TREATMENT AND OUTCOME
Placebo therapy (with parental consent) was prescribed with favourable results.
CONCLUSION
We examine the ethical considerations for and against placebo therapy, and explore the role of placebo therapy in the management of psychogenic movement disorders.
引言
精神性运动障碍的管理充满困难。同理心和无评判的态度在对待患者时至关重要，对症状的神经生物学解释可能有助于建立信任、促进接受、理解和康复。
临床表现
我们报告一名17岁的中国女孩患有精神性眼睑痉挛。她的父母拒绝心理治疗和药物治疗。
治疗与结果
在获得家长同意的情况下给予安慰剂治疗，结果良好。
结论
我们审视了支持和反对安慰剂治疗的伦理考量，并探讨了安慰剂治疗在精神性运动障碍管理中的作用。
Zotero 插件